Catalyst Biosciences
Stock Forecast, Prediction & Price Target

Catalyst Biosciences Financial Estimates

Catalyst Biosciences Revenue Estimates

Catalyst Biosciences EBITDA Estimates

Catalyst Biosciences Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2020 12/31/2021 12/31/2022 12/31/2025
Revenue
 
% change YoY
$20.94M
 
N/A
$7.33M
 
-64.97%
$794K
 
-89.17%
Avg: $3.17M
Low: $3.17M
High: $3.17M
avg. 300%
Net Income
 
% change YoY
$-55.54M
 
N/A
$-87.89M
 
-58.24%
$-8.24M
 
90.62%
Avg: $-638K
Low: $-630.91K
High: $-630.91K
avg. 92.25%
EBITDA
 
% change YoY
$-57.37M
 
N/A
$-87.60M
 
-52.70%
$-52.15M
 
40.46%
Avg: $-1.90M
Low: $-1.90M
High: $-1.90M
avg. 96.34%
EPS
 
% change YoY
-$2.9
 
N/A
-$2.87
 
1.03%
-$0.26
 
90.94%
Avg: -$0.02
Low: -$0.02
High: -$0.02
avg. 92.30%
Operating Expenses
 
% change YoY
$69.15M
 
N/A
$87.85M
 
27.03%
$30.40M
 
-65.39%
Avg: $3.03M
Low: $3.03M
High: $3.03M
avg. -90.02%

FAQ

What is Catalyst Biosciences stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 92.25% in 2025-2025.

We have gathered data from 1 analysts. Their low estimate is -630.91K, average is -638K and high is -630.91K.

What is Catalyst Biosciences stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 300% in 2025-2025.

We have gathered data from N/A analysts. Their low revenue estimate is $3.17M, average is $3.17M and high is $3.17M.

What is Catalyst Biosciences stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 92.30% in 2025-2025.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.02, average is -$0.02 and high is $-0.02.